Nov. 13, 2023—Vanderbilt research finds antiviral medications are underused in young children diagnosed with influenza despite national guidelines supporting their use
Nov. 8, 2023—The current flu season has started later and more gradually than last year although cases are expected to begin increasing in November before falling off in March.
Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects
Jul. 24, 2023—A Vanderbilt study is among the first to quantify how often children diagnosed with flu experience serious neuropsychiatric side effects.
Mar. 2, 2023—Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.
Feb. 2, 2023—A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.
Dec. 21, 2022—Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
Aug. 4, 2022—A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment.
Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
Mar. 17, 2022—A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.